Psoriasiform reactions of anti-PD-1-treated patients were weakly immunoreactive for the type I IFN-α2A, at lower levels than paradoxical psoriasis induced by anti-TNF-α (~1.6-fold decrease) (Figure 3). Here, PDCD1 is linked to psoriasis.